Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now NasdaqCM - Nasdaq Real Time Price • USD MEDIROM Healthcare Technologies Inc. (MRM) Follow Compare 0.8500 +0.0500 +(6.25%) At close: February 21 at 4:00:00 PM EST All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations MEDIROM Healthcare Technologies Inc. Announces Preliminary, Unaudited Financial Results for Full Year 2024 Under Japanese GAAP Sustained Revenue Growth / Operating ProfitabilityNEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a holistic healthcare company based in Japan (the “Company”), today announced its preliminary, unaudited consolidated financial results for the year ended December 31, 2024, prepared under Japanese generally accepted accounting principles (“JGAAP”). These preliminary financial results and management’s estimates included in this press release are unr MEDIROM Healthcare Technologies Inc. Announces December 2024 Key Performance Indicators (KPIs) Total Customers Served: 80,764 – Sales Per Customer: JPY 7,384 – Customer Repeat Ratio: 77.6%TOKYO, Jan. 29, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company based in Japan (the “Company”), today announced its major Key Performance Indicators, or KPIs, updated for the month of December 2024. Data is provided for all salons for which comparable financial and customer data is available and excludes certain salons where such information is Completion of Offering and Increase in Registered Capital TOKYO, Jan. 21, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (the “Company” or “MEDIROM”), a health technology and holistic healthcare company headquartered in Tokyo, Japan and led by CEO Kouji Eguchi, announces that, on January 14, 2025, all corporate capital registration procedures under Japanese law were completed with respect to the Company’s offering of 2,860,000 common shares represented by American Depositary Shares, generating gross proceeds of approximatel MEDIROM MOTHER Labs Provides MOTHER Bracelet®︎ Device and Remote Health Monitoring System, REMONY, to TOPPAN Inc. TOKYO, Jan. 21, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare technologies Inc. (NASDAQ: MRM) (“MEDIROM”), a health technology and holistic healthcare company headquartered in Tokyo, Japan and led by CEO Kouji Eguchi, is pleased to announce that its subsidiary, MEDIROM MOTHER Labs Inc. (“MOTHER Labs”) is now providing its remote health monitoring system, REMONY, and charging-free smart tracker device, MOTHER Bracelet®︎, to the Electronics Division of TOPPAN Inc. (Tokyo Stock Exchange: 7911). In re MEDIROM Healthcare Technologies Inc. Announces November 2024 Key Performance Indicators (KPIs) Total Customers Served: 75,760 – Sales Per Customer: JPY 7,055 – Customer Repeat Ratio: 77.5%TOKYO, Dec. 23, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company based in Japan (the “Company”), today announced its major Key Performance Indicators, or KPIs, updated for the month of November 2024. Data is provided for all salons for which comparable financial and customer data is available and excludes certain salons where such information is MEDIROM Healthcare Technology‘s Subsidiary, MEDIROM MOTHER Labs, Raises an Aggregate Total of JPY260.3 Million in its Series A Financing Round Pre-Money Valuation of JPY9 Billion is Approximately Multiples of Current Parent Company Market Capitalization.Strategic Investors Further Validation of Technology and Growth Potential.Further Commercialization with Recent 25,000 Unit Order from B2B Sales Channel. TOKYO, Dec. 13, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) announces that its subsidiary MEDIROM MOTHER Labs Inc. raised to date an aggregate total of 260.3 million yen (approximtaely USD $ [1.7] millio MEDIROM Healthcare Technologies Inc. Announces Closing of Public Offering TOKYO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM), “MEDIROM”, a holistic healthcare company that operates over 300 wellness salons across Japan and provides healthcare services, today announced the closing of its public offering of 2,860,000 American Depositary Shares at a public offering price of $1.75 per share, for gross proceeds of approximately $5,000,000 before deducting underwriting discounts and offering expenses. In addition, MEDIROM has granted Two Senior MEDIROM Mother Labs Executives Invest in Mother Labs’ Series A Financing at a Pre-Money Valuation of JPY9 Billion (as of December 1, 2024, approximately USD $59,000,000) TOKYO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (the “Company” or “MEDIROM”) announces that two senior executives, Issei Homan, Chief Technology Officer of MEDIROM MOTHER Labs Inc. (“Mother Labs”), a subsidiary of MEDIROM, and Yasuhiro Hayami, Chief Business Officer of Mother Labs, invested in Mother Labs’ Series A financing at a pre-money valuation of of JPY9 billion (as of December 1, 2024, approximately USD $59,000,000). Messrs. Homan and Hayami are MEDIROM Healthcare Technologies Inc. Announces Pricing of Public Offering TOKYO, Dec. 09, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM), “MEDIROM”, a holistic healthcare company that operates over 300 wellness salons across Japan and provides healthcare services, today announced the pricing of a public offering of 2,860,000 American Depositary Shares at a public offering price of $1.75 per share, for gross proceeds of approximately $5,000,000, before deducting underwriting discounts and offering expenses. In addition, MEDIROM has granted UPDATE: MEDIROM Healthcare Technologies Has Received Orders for Over 25,000 MOTHER Bracelet Units TOKYO, Dec. 09, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“MEDIROM”) announces that its subsidiary MEDIROM MOTHER Labs Inc. has received orders for over 25,000 MOTHER Bracelet units, including orders from Japanese companies such as NFES Technologies Inc. “Our long-term mission is for the Mother Bracelet to be revolutionary in the Healthcare Technology and Wellness industries. The 25,000 unit MOTHER Bracelet orders surpasses the amount we’ve received and fulfill MEDIROM Healthcare Technologies Has Received Orders for Over 25,000 MOTHER Bracelet Units TOKYO, Dec. 09, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“MEDIROM”) announces that its subsidiary MEDIROM MOTHER Labs Inc. has received orders for over 25,000 MOTHER Bracelet units, including orders from Japanese companies such as NFES Technologies Inc. “Our long-term mission is for the Mother Bracelet to be revolutionary in the Healthcare Technology and Wellness industries. The 25,000 unit MOTHER Bracelet orders surpasses the amount we’ve received and fulfill M3 Group Joins MEDIROM Mother Labs’ Series A Financing Round at JPY9 Billion (as of December 1, 2024, approximately USD $59,000,000) Pre-Money Valuation TOKYO, Dec. 06, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“MEDIROM”) announces that M3, Inc. (TOKYO PRIME: 2413), or an affiliate within the M3 group, is participating in the Series A equity financing round of MEDIROM MOTHER Labs Inc., a subsidiary of MEDIROM. NFES Technologies Inc. is the lead investor of the Series A financing round at a pre-money valuation of JPY9 billion. Additional information is available here: https://medirom.co.jp/en/ir/20240824/6148%09 MEDIROM Reports Revenue Growth Despite Asset Decline MEDIROM Healthcare Technologies (MRM) has released an update. MEDIROM Healthcare Technologies reported a total revenue increase to ¥3.48 billion for the first half of 2024, compared to ¥3.15 billion in the same period of 2023, driven primarily by growth in their directly-operated salons. However, their total assets decreased from ¥6.85 billion to ¥5.83 billion, resulting in a shareholders’ deficit of ¥364.3 million as of June 30, 2024. Investors should note the company’s financial strategy and p Healthy and Beauty Synergies: MEDIROM Healthcare Technologies and SBC Medical Group Holdings Announce Business Alliance TOKYO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) announced a business alliance with SBC Medical Group Holdings Incorporated (Nasdaq: SBC) a global owner, operator and provider of management services and products to cosmetic treatment centers. Our two leading healthcare service providers have more than 4 million members across their loyalty programs at SBC’s “Shonan Beauty Clinic” and MEDIROM’s “Re.Ra.Ku wellness salon”. In addition to bringing customers Lead Real Estate Co., LTD Introduces Fitness Tracker “MOTHER Bracelet®︎” to ENT TERRACE and Invites Activities that Lead to Social Support ENT TERRACE extended-stay hotel brand, operated by Lead Real Estate Co., Ltd. offering MOTHER Bracelet. Image courtesy of Lead Real Estate Co., ltd. ENT TERRACE extended-stay hotel brand, operated by Lead Real Estate Co., Ltd. offering MOTHER Bracelet. Image courtesy of Lead Real Estate Co., ltd. Mother Bracelet Mother Bracelet Lead Real Estate Co., LTD Lead Real Estate Co., LTD ENT TERRACE ENT TERRACE MEDIRON MOTHER Labs Inc. MEDIRON MOTHER Labs Inc. TOKYO, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Lea MEDIROM Partners with Elematec to Boost Health Tech MEDIROM Healthcare Technologies (MRM) has released an update. MEDIROM Healthcare Technologies’ subsidiary, MEDIROM MOTHER Labs, has entered a strategic alliance with Elematec Corporation, a member of the Toyota Tsusho group, which includes a significant investment in MOTHER Labs’ Series A funding. This partnership aims to amplify the distribution of MEDIROM’s innovative MOTHER Bracelet, a health-monitoring device that operates without recharging. The collaboration is expected to leverage Elemate Top Midday Gainers Top Midday Gainers Elematec Corporation Forms a Business Alliance with and Agrees to Make a Strategic Investment in MEDIROM Healthcare Technologies’ MOTHER Labs Subsidiary TOKYO, Oct. 15, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) announces that its subsidiary MEDIROM MOTHER Labs Inc. has formed a capital and business alliance with Elematec Corporation (TOKYO PRIME: 2715), a member of the Toyota Tsusho Corporation group. Under the capital and business alliance agreement, Elematec Corporation has agreed to make a strategic investment in MEDIROM MOTHER Labs’ Series A round at a pre-money valuation of 9 billion yen (approximately US$6 MEDIROM Healthcare Secures New Investment Bonds MEDIROM Healthcare Technologies (MRM) has released an update. MEDIROM Healthcare Technologies Inc. has entered into a purchase agreement with Triple One Investment Partnership for the issue of 2nd unsecured convertible-type corporate bonds with share options, totaling JPY 300,000,000. The bonds will be issued on October 25, 2024, with payment due by October 11, 2024. The agreement includes clauses that prevent the transfer of the bonds to third parties without consent and excludes the appointmen MEDIROM Rehab Solutions Inc. Acquires Rehabilitation Centers from Y’s, Inc. TOKYO, Oct. 07, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“Medirom” or the “Company”) is pleased to announce that it is capitalizing on its extensive experience operating wellness clinics and healthcare technology to expand into the rehabilitation industry. In doing so, MEDIROM established a wholly-owned subsidiary, MEDIROM Rehab Solutions Inc., which acquired all of the rehabilitation centers of Y’s, Inc. Prior to the acquisition by MEDIROM Rehab Solutions Inc Performance Overview Trailing total returns as of 2/24/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD Return MRM MSCI WORLD YTD -18.27% +3.72% 1-Year -85.83% +15.34% 3-Year -87.54% +32.34%